
PMC:7376845 / 29224-29374
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T212 | 93-97 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
723 | 124-132 | Species | denotes | SARS-CoV | Tax:694009 |
724 | 139-149 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T284 | 124-132 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T285 | 124-128 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T286 | 139-147 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T287 | 139-143 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T310 | 11-13 | http://purl.obolibrary.org/obo/CLO_0008922 | denotes | S2 |
T311 | 11-13 | http://purl.obolibrary.org/obo/CLO_0050052 | denotes | S2 |
T312 | 93-97 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T252 | 11-13 | Chemical | denotes | S2 | http://purl.obolibrary.org/obo/CHEBI_29387 |
T253 | 48-55 | Chemical | denotes | antigen | http://purl.obolibrary.org/obo/CHEBI_59132 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 93-115 | http://purl.obolibrary.org/obo/GO_0002456 | denotes | cell-mediated immunity |
T5 | 93-115 | http://purl.obolibrary.org/obo/GO_0002449 | denotes | cell-mediated immunity |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T228 | 0-150 | Sentence | denotes | Hence, the S2 subunit may serve as an important antigen for inducing both humoral as well as cell-mediated immunity against SARS-CoV-1 and SARS-CoV-2. |